Neutral displacement needleless connectors market set to hit $1.22 billion by 2030

The neutral displacement needleless connectors market is growing as hospitals push harder on infection control and safer IV access. The Business Research Company forecasts the market will rise from $0.87 billion in 2026 to $1.22 billion by 2030, with North America leading today and Asia-Pacific expected to grow fastest.

Why it matters: - Neutral displacement needleless connectors help prevent blood reflux, catheter blockage and contamination during IV access. - The devices support safer patient care as hospitals try to reduce hospital-acquired infections and bloodstream infections. - Demand is rising across hospital and home-based IV therapy settings, where infection prevention is a high priority.

What happened: - The Business Research Company released a 2026 market report on neutral displacement needleless connectors. - The market is estimated at $0.87 billion in 2026, up from $0.8 billion in 2025. - The report projects the market will reach $1.22 billion by 2030. - The report places North America as the largest regional market in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - The market posted 8.6% CAGR growth in the historical period from 2025 to 2026. - The report forecasts 8.9% CAGR growth from 2026 to 2030. - Historical growth was supported by more catheter-related bloodstream infections, wider use of intravenous drug delivery, early needleless access technologies, stricter hospital infection control protocols, and higher awareness of healthcare-associated infection risks. - Future growth is expected to come from expanding hospital infrastructure and critical care units, more home-based IV therapies, tighter infection-prevention rules, more chronic disease treatment requiring long-term IV access, and anti-reflux valve connector technology. - The report highlights growing use of closed system IV access solutions, wider adoption of anti-reflux connectors, needleless IV systems designed to improve worker safety, single-use sterile IV connectors in hospitals, and advanced valve mechanisms for better flow control and safety. - Neutral displacement needleless connectors maintain neutral pressure within the catheter during IV access. - Neutral pressure helps reduce fluid reflux, which can cause blood backflow and catheter blockage. - The devices are designed to lower infection and catheter complication risks during repeated IV access. - The report includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - Rising infection-control pressure is doing more than shaping procurement; it is helping justify adoption of IV access products that can reduce complications and avoid downstream treatment costs. - Surgical activity also supports demand because procedures require reliable, sterile access for fluid and drug delivery. - The report cites US Centers for Disease Control and Prevention data showing about a 4% increase in the standardized infection ratio for surgical site infections in January 2024 versus the prior year. - The report cites American Society of Plastic Surgeons data showing liposuction was the most popular plastic surgery in 2023, with nearly 350,000 procedures, up 7% from 2022.

What's next: - Market growth will likely track hospital expansion, chronic disease treatment volumes and adoption of newer anti-reflux connector designs. - Asia-Pacific’s faster growth suggests suppliers may focus more attention on that region’s healthcare infrastructure buildout and IV therapy demand. - The Business Research Company is offering a free sample of the report and the full market report online. - Download the sample report - Read the full market report

The bottom line: - Neutral displacement needleless connectors are moving from a niche IV accessory to a broader infection-control tool in a market that is still early in its growth curve.